当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析

亚虹医药-U

(688176)

  

流通市值:56.03亿  总市值:73.45亿
流通股本:4.36亿   总股本:5.71亿

亚虹医药-U(688176)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-1.14亿元,每股收益-0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益145130.95万元,未分配利润-195739.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产199517.67万元,负债54386.72万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入71,085,894.94277,121,519.19216,408,302.14130,237,475.13
营业总成本189,734,751.55726,362,997.2492,121,292.52315,289,508.12
其他经营收益
营业利润-112,359,970.17-428,326,573.36-258,185,335.83-167,498,407.9
利润总额-114,384,224.42-433,405,537.09-261,643,797.65-170,534,193.48
净利润-114,495,059.33-432,745,046.85-261,050,841.03-170,012,214.31
每股收益
其他综合收益1,173,877.89-1,487,000.35244,644.07824,831.05
综合收益总额-113,321,181.44-434,232,047.2-260,806,196.96-169,187,383.26
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,635,087,629.971,761,747,845.081,831,875,409.941,853,436,367.24
非流动资产:
非流动资产合计360,089,026.45295,744,968.14316,824,572.54321,224,052.73
资产总计1,995,176,656.422,057,492,813.222,148,699,982.482,174,660,419.97
流动负债:
流动负债合计401,380,914.21402,396,549.09367,297,502.27312,730,467.19
非流动负债:
非流动负债合计142,486,244.7392,040,464.6145,195,805.9847,072,296.73
负债合计543,867,158.94494,437,013.7412,493,308.25359,802,763.92
所有者权益(或股东权益):
归属于母公司股东权益合计1,466,747,909.331,576,339,574.941,744,502,159.341,819,476,153.99
股东权益合计1,451,309,497.481,563,055,799.521,736,206,674.231,814,857,656.05
负债和股东权益合计1,995,176,656.422,057,492,813.222,148,699,982.482,174,660,419.97
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计74,577,942.28280,533,929.51216,356,522.64136,005,902.27
经营活动现金流出小计199,082,409.29692,327,604.31518,155,423.76330,277,080.67
经营活动产生的现金流量净额-124,504,467.01-411,793,674.8-301,798,901.12-194,271,178.4
投资活动产生的现金流量:
投资活动现金流入小计480,925,754.391,690,865,081.844,558,419,963.773,333,733,553.9
投资活动现金流出小计448,726,247.341,653,244,958.394,618,713,630.263,373,608,447.24
投资活动产生的现金流量净额32,199,507.0537,620,123.45-60,293,666.49-39,874,893.34
筹资活动产生的现金流量:
筹资活动现金流入小计106,790,000296,119,431.84239,359,346.39167,647,243.72
筹资活动现金流出小计95,088,310.3589,956,151.1358,270,569.8146,701,462.61
筹资活动产生的现金流量净额11,701,689.65206,163,280.71181,088,776.58120,945,781.11
汇率变动对现金及现金等价物的影响-350,302.24-1,679,325.05-385,166.51-308,215.1
现金及现金等价物净增加额-80,953,572.55-169,689,595.69-181,388,957.54-113,508,505.73
期末现金及现金等价物余额369,991,797.87450,945,370.42439,246,008.57507,126,460.38
补充资料:
现金及现金等价物的净增加额--169,689,595.69--113,508,505.73
最新报告期:2026-05-03
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中金公司张琎,刘雅馨,朱言音-0.76-0.38--2026-05-03
太平洋周豫,戎晓婕-0.44-0.02--2026-03-16
华鑫证券吴景欢,胡博新-0.73-0.55-0.262026-03-11
兴业证券孙媛媛,杨希成,黄翰漾-0.73-0.60-0.372026-03-06
TOP↑